ATS 2021

Tezepelumab for severe asthma – a rising star

Presented By

Prof. Michael E. Wechsler, National Jewish Health, Denver, Colorado, USA

Conference

ATS 2021

20 May, 2021 10:36

Antibody cocktail is efficacious in COVID-19 outpatients

Presented By

Dr Julie V. Philley, University of Texas Health Science Center, Tyler, USA

Conference

ATS 2021

20 May, 2021 10:35

IL-4/IL-13 blockade successful in children with uncontrolled moderate-to-severe asthma

Presented By

Prof. Leonard B. Bacharier, Vanderbilt University Medical Center, Tennessee, USA

Conference

ATS 2021

20 May, 2021 10:35

Air pollution: A driver of COVID-19 morbidity and mortality

Presented By

Prof. Meredith McCormack, John Hopkins University, Baltimore, USA

Conference

ATS 2021

20 May, 2021 10:34

Novel evidence for CPAP: patients with higher ∆HR benefit most

Presented By

Prof. Ali Azarbarzin, Harvard Medical School, Massachusetts, USA

Conference

ATS 2021

20 May, 2021 10:34

IPF: Early therapy reduces hospitalisation in a real-world scenario

Conference

ATS 2021

18 May, 2021 10:49

Cystic fibrosis patients with advanced lung disease benefit from longer-term triple therapy

Conference

ATS 2021

18 May, 2021 10:39

Potential genetic risk factors for COVID-19 identified

Presented By

Dr Ana Hernandez Cordero, Centre for Heart Lung Innovation, University of British Columbia, Canada

Conference

ATS 2021

18 May, 2021 10:30

Tobacco biomarkers disappoint in prediction of lung cancer risk

Presented By

Dr Christine Lambert, University of Minnesota, USA

Conference

ATS 2021

18 May, 2021 10:24

COVID-19 infection risk in sleep apnoea linked to adequate apnoea treatment

Presented By

Dr Dennis Hwang, Kaiser Permanente, California, USA

Conference

ATS 2021

18 May, 2021 10:17

Anti-IL-5 therapy for severe asthma – convincing real-world data

Presented By

Dr Donna Carstens, AstraZeneca, Wilmington, Delaware, USA

Conference

ATS 2021

17 May, 2021 10:39

Obstructive lung diseases and COVID-19 – a deadly combination?

Conference

ATS 2021

17 May, 2021 10:38

High NO2 concentration in winter: a risk factor for ILD patients

Presented By

Dr Marya Ghazipura, Marron Institute of Urban Management, NY, USA

Conference

ATS 2021

17 May, 2021 10:33

Increased all-cause mortality during severe exacerbations in COPD patients

Presented By

Prof. Manoj J. Mammen, Jacobs School of Medicine and Biomedical Sciences, New York, USA

Conference

ATS 2021

17 May, 2021 10:26

Vaping increases the risk for asthma

Presented By

Prof. Teresa To, The Hospital for Sick Children, Toronto, Canada

Conference

ATS 2021

17 May, 2021 10:18